Abstract
Opioids are the most powerful drugs for the treatment of severe acute and chronic pain. However, their widespread use has been hampered by side effects such as depression of breathing, nausea, clouding of consciousness, constipation, addiction and tolerance [1]. A new generation of opioid drugs is now underway. This new class selectively activates opioid receptors outside the central nervous system, thus avoiding all centrally-mediated unwanted effects while exerting potent analgesic and anti-inflammatory actions [2,3]. In addition, endogenous ligands at peripheral opioid receptors are produced within immune cells and such immune-derived opioids can inhibit pain [4]. This heralds an entirely new field, the selective targeting of opioid peptide-containing cells to sites of painful tissue injury and the augmentation of opioid synthesis by gene transfer. These novel concepts of pain control and anti-inflammatory actions open exciting prospects for future therapeutic approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kieffer BL, Gaveriaux-Ruff C (2002) Exploring the opioid system by gene knockout.Prog Neurobiol66: 285–306
Brower V (2000) New paths to pain relief.Nat Biotechnol18: 387–391
Walker JS (2003) Anti-inflammatory effects of opioids. In: H Machelska, C Stein (eds):Immune mechanisms of pain and analgesia. Landes Bioscience, Georgetown and Kluwer Academic, New York, 148–160
Machelska H, Stein C (2002) Immune mechanisms in pain control.Anesth Analg95:1002–1008
Stein C, Machelska H, Schäfer M (2001) Peripheral analgesic and anti-inflammatory effects of opioids.Z Rheumatol60: 416–424
Coggeshall RE, Zhou S, Carlton SM (1997) Opiate receptors on peripheral sensory axons.Brain Res764: 126–132
Pare M, Elde R, Mazurkiewicz JE, Smith AM, Rice FL (2001) The Meissner corpuscle revised: A multiafferented mechanoreceptor with nociceptor immunochemical properties.J Neurosci21: 7236–7246
Mousa SA, Machelska H, Schafer M, Stein C (2002) Immunohistochemical localizationof endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain.J Neuroimmunol126: 5–15
Stein C, Pfluger M, Yassouridis A, Hoelzl J, Lehrberger K, Welte C, Hassan AH (1996)No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia.J Clin Invest98: 793–799
Hassan AHS, Ableitner A, Stein C, Herz A (1993) Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue.Neuroscience55: 185–195
Mousa SA, Zhang Q, Sitte N, Ji R, Stein C (2001) Beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue.J Neuroimmunol115: 71–78
King M, Su W, Chang A, Zuckerman A, Pasternak GW (2001) Transport of opioids from the brain to the periphery by P-glycoprotein: Peripheral actions of central drugs.Nat Neurosci4: 268–274
Zhou L, Zhang Q, Stein C, Schäfer M (1998) Contribution of opioid receptors on primary afferentversussympathetic neurons to peripheral opioid analgesia.J Pharmacol Exp Ther286: 1000–1006
Pertovaara A, Wei H (2001) Peripheral effects of morphine in neuropathie rats: Role of sympathetic postganglionic nerve fibers.Eur J Pharmacol429: 139–145
Gebhart GF, Su X, Joshi S, Ozaki N, Sengupta JN (2000) Peripheral opioid modulation of visceral pain.Ann NY Acad Sci909: 41–50
Kalso E, Smith L, McQuay HJ, Moore RA (2002) No pain, no gain: Clinical excellence and scientific rigour — Lessons learned from IA morphine.Pain98: 269–275
Sharp BM (2003) Opioid receptor expression and intracellular signaling by cellsinvolved in host defence and immunity. In: H Machelska, C Stein C (eds):Immune mechanisms of pain and analgesia.Landes Bioscience, Georgetown and Kluwer Academic, New York, 98–103
Zadina JE, Hackler L, Ge LJ, Kastin AJ (1997) A potent and selective endogenous agonist for the mu-opiate receptor.Nature386: 499–502
Smith EM (2003) Opioid peptides in immune cells. In: H Machelska, C Stein C (eds):Immune mechanisms of pain and analgesia.Landes Bioscience, Georgetown and Kluwer Academic, New York, 51–63
Cabot PJ, Carter L, Schafer M, Stein C (2001) Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain.Pain93: 207–212
Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schafer M, Loeffler JP, Stein C (1997) Immune cell-derived ß-endorphin: Production, release and control of inflammatory pain in rats.J Clin Invest100: 142–148
Przewlocki R, Hassan AHS, Lason W, Epplen C, Herz A, Stein C (1992) Gene expression and localization of opioid peptides in immune cells of inflamed tissue. Functional role in antinociception.Neuroscience48: 491–500
Stein C, Hassan AHS, Lehrberger K, Giefing J, Yassouridis A (1993) Local analgesic effect of endogenous opioid peptides.Lancet342: 321–324
Rittner HL, Brack A, Machelska H, Mousa SA, Bauer M, Schafer M, Stein C (2001) Opioid peptide expressing leukocytes-identification, recruitment and simultaneously increasing inhibition of inflammatory pain.Anesthesiology95: 500–508
Jessop DS, Richards LJ, Harbuz MS (2002) Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation.Ann NY Acad Sci966: 456–463
Braz J, Beaufour C, Coutaux A, Epstein AL, Cesselin F, Hamon M, Pohl M (2001) Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin over-production in sensory neurons.J Neurosci21: 7881–7888
Parsons CG, Czlonkowski A, Stein C, Herz A (1990) Peripheral opioid receptors mediating antinociception in inflammation. Activation by endogenous opioids and role of the pituitary-adrenal axis.Pain41: 81–93
Wintzen M, Yaar M, Burbach JP, Gilchrest BA (1996) Pro-opiomelanocortin gene product regulation in keratinocytes.J Invest Dermatol106: 673–678
Khodorova A, Fareed MU, Gokin A, Strichartz GR, Davar G (2002) Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner.J Neurosci22: 7788–7796
von Andrian UH, Mackay CR (2000) T-cell function and migration. Two sides of the same coin.N Engl J Med343: 1020–1034
Mousa SA, Machelska H, Schäfer M, Stein C (2000) Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain.J Neuroimmunology108: 160–170
Machelska H, Mousa SA, Brack A, Schopohl JK, Rittner HL, Schäfer M, Stein C (2002)Peripheral analgesic and anti-inflammatory effects of opioids — Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1.J Neurosci22: 5588–5596
Machelska H, Cabot PJ, Mousa SA, Zhang Q, Stein C (1998) Pain control in inflammation governed by selectins.Nat Med4: 1425–1428
Schafer M, Mousa SA, Stein C (1997) Corticotropin-releasing factor in antinociception and inflammation.Eur J Pharmacol323: 1–10
Mousa SA, Schafer M, Mitchell WM, Hassan AH, Stein C (1996) Local up-regulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation.Eur J Pharmacol311: 221–231
Radulovic M, Dautzenberg FM, Sydow S, Radulovic J, Spiess J (1999) Corticotropinreleasing factor receptor 1 in mouse spleen: Expression after immune stimulation and identification of receptor-bearing cells.J Immunol162: 3013–3021
Schäfer M, Carter L, Stein C (1994) Interleukin-113 and corticotropin-releasing-factor inhibit pain by releasing opioids from immune cells in inflamed tissue.Proc Natl Acad Sci USA91: 4219–4223
Stein C, Gramsch C, Herz A (1990) Intrinsic mechanisms of antinociception in inflammation. Local opioid receptors and beta-endorphin.J Neurosci10: 1292–1298
Stein C, Hassan AHS, Przewlocki R, Gramsch C, Peter K, Herz A (1990) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.Proc Natl Acad Sci USA7: 5935–5939
Schäfer M, Mousa SA, Zhang Q, Carter L, Stein C (1996) Expression of corticotropinreleasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia.Proc Natl Acad Sci USA93: 6096–6100
Hong Y, Abbott FV (1995) Peripheral opioid modulation of pain and inflammation in the formalin test. EurJ Pharmacol277: 1317–1327
Jin S, Lei L, Wang Y, Da D, Zhao Z (1999) Endomorphin-1 reduces carrageenaninduced fos expression in the rat spinal dorsal horn.Neuropeptides33: 281–284
Khalil Z, Sanderson K, Modig M, Nyberg F (1999) Modulation of peripheral inflammation by locally administered endomorphin-1.Inflamm Res48: 550–556
Stein A, Yassouridis A, Szopko C, Helmke K, Stein C (1999) Intra-articular morphineversusdexamethasone in chronic arthritis.Pain83: 525–532
Horwell DC (1988) Kappa opioid analgesics.Drugs Future13: 1061–1070
Wilson JL, Nayanar V, Walker JS (1996) The site of anti-arthritic action of the kappa agonist, U50488H: Importance of local administration.Br J Pharm118: 1754–1760
Binder W, Walker JS (1998) The peripherally selective kappa-opioid agonist, asimadoline, attenuates adjuvant arthritis.Br J Pharm124: 647–654
Barber A, Gottschlich R (1992) Opioid agonists and antagonists: An evaluation of their peripheral actions in inflammation.Med Res Rev12: 525–562
Giardina G, Clarke GD, Grugni M, Sbacchi M, Vecchietti V (1995) Central and peripheral analgesic agents: Chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classes.Farmaco50: 405–418
Barber A, Gottschlich R (1997) Central and peripheral nervous system. Novel develop-ments with selective, non-peptidic kappa-opioid receptor agonists. Exp Opin Invest Drugs 6: 1351–1368
Barber A, Bartoszyk GD, Bender HM, Gottschlich R, Greiner HE, Harting J, Mauler F, Minck KO, Murray RD, Simon M (1994) A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.Br J Pharmacol113: 1317–1327
Machelska H, Pflüger M, Weber W, Piranvisseh-Völk M, Daubert JD, DeHaven R, Stein C (1999) Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.J Pharmacol Exp Ther290: 354–361
Sandner-Kiesling A, Pan HL, Chen SR, James RL, DeHaven-Hudkins DL, Dewan DM, Eisenach JC (2002) Effect of kappa opioid agonists on visceral nociception induced by uterine cervical distension in rats.Pain96: 13–22
Binder W, Machelska H, Mousa S, Schmitt T, Riviere PJ, Jumen JL, Stein C, Schafer M (2001) Analgesic and anti-inflammatory effects of two novel kappa opioid peptides.Anesthesiology94: 1034–1044
Yaksh TL (1988) Substance P release from knee joint afferent terminals: Modulation by opioids.Brain Res458: 319–324
Binder W, Scott C, Walker JS (1999) Involvement of substance P in the anti-inflammatory effects of the peripherally selective x-opioid, asimadoline and the NK1 antagonist GR205171.Eur J Neurosci 11: 2065–2072
Sacerdote P, Limiroli E, Gaspani L (2002) Experimental evidence for immunomodulatory effects of opioids. In: H Machelska, C Stein C (eds):Immune mechanisms of pain and analgesia.Landes Bioscience, Georgetown and Kluwer Academic, New York, 106–112
Wilson JL, Walker JS, Antoon JS, Perry MA (1998) Intercellular adhesion molecule-1 expression in adjuvant arthritis in rats: Inhibition by kappa-opioid agonist but not by NSAID.J Rheumatol25: 499–505
Polydefkis M, Yiannoutsos CT, Cohen BA, Hollander H, Schifitto G, Clifford DB, Simpson DM, Katzenstein D, Shriver S, Hauer P et al. (2002) Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy.Neurology58: 115–119
Lu CY, Chou AK, Wu CL, Yang CH, Chen JT, Wu PC, Lin SH, Muhammad R, Yang LC (2002) Gene-gun particle with pro-opiomelanocortin cDNA produces analgesia against formalin-induced pain in rats.Gene Ther9: 1008–1014
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Basel AG
About this chapter
Cite this chapter
Machelska, H., Stein, C. (2003). Peripheral analgesic and anti-inflammatory effects of opioids — neuro-immune crosstalk. In: Schäfer, M., Stein, C. (eds) Mind over Matter - Regulation of Peripheral Inflammation by the CNS. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8039-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8039-8_9
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9416-6
Online ISBN: 978-3-0348-8039-8
eBook Packages: Springer Book Archive